WDNA - WisdomTree BioRevolution Fund
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
As of May 15, 2026: spot at $13.68, ATM IV 169.9%, net GEX $9.
- Sector
- Financial Services
- Industry
- Asset Management
- Market Cap
- $2.3M
- Beta
- 1.30
- 52-Week Range
- 11.986-18.878
- Dividend Yield
- $0.77
- IPO Date
- Jun 3, 2021
- Exchange
- CBOE
What WDNA Looks Like to Options Traders Today
IV rank of 42.7% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; positive net gamma exposure ($9) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (-0.417) prices puts richer than calls, the typical equity downside-protection skew.
What This Page Covers
The WDNA overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
Frequently asked WDNA overview questions
- What is WDNA?
- WDNA is the ticker symbol for WisdomTree BioRevolution Fund, an listed exchange-traded fund. The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. Listed on CBOE. WDNA is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What does the WDNA options snapshot look like today?
- As of May 15, 2026, the WDNA options snapshot shows spot at $13.68, ATM IV 169.9%, IV rank 42.7%, net GEX $9, expected move 48.71%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are WDNA's key statistics?
- WisdomTree BioRevolution Fund (WDNA) carries a market capitalization of $2.3M, 52-week range of 11.986-18.878. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does WDNA belong to?
- WisdomTree BioRevolution Fund operates in the Financial Services sector, in the Asset Management industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare WDNA's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the WDNA data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.